Trial intelligence / Profile preview

Simvastatin 40 mg in Hypercholesterolemia

NCT00398294Phase 4Completed

Sponsor
Organon & Co.
Start
May 2005
Primary completion
Apr 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of simvastatin in hypercholesterolemia, sponsored by Organon & Co. Primary endpoints: Total Cholesterol at 12 weeks, Low-Density Lipoprotein Cholesterol at 12 weeks and 2 more. Started May 2005; status: completed.

02

Drugs

simvastatin
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT00398294.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00398294.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call